𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations and molecular variants of the NBS1 gene in non-Hodgkin lymphoma

✍ Scribed by Karen M. Cerosaletti; V. Anne Morrison; Daniel E. Sabath; Dennis M. Willerford; Patrick Concannon


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
73 KB
Volume
35
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Non‐Hodgkin lymphomas (NHLs) are characterized by chromosomal translocations that juxtapose loci encoding lymphoid antigen receptors with cellular proto‐oncogenes. These translocations are thought to arise from inaccurate processing of DNA breaks created during physiologic recombination of the antigen receptor genes in lymphocytes. The inherited disorders ataxia‐telangiectasia and Nijmegen breakage syndrome are caused by mutations in the ATM and NBS1 genes, respectively, and are characterized by generalized genomic instability and a high incidence of lymphoid cancers. Lymphoid cells from patients with either disorder frequently have chromosomal translocations involving T‐cell‐receptor or immunoglobulin loci. To investigate the potential role of the NBS1 gene in the pathogenesis of NHL, we screened tumor DNA samples from 91 sporadic cases of NHL and genomic DNA from 154 control individuals for mutations in all 16 exons of the NBS1 gene and in flanking intronic sequences. One NHL case with a truncating mutation in NBS1 and a second NHL case with a putative missense mutation were detected. Neither mutation was observed among controls. Three additional putative missense mutations were observed only in the normal control samples. A panel of six common polymorphisms spanning the NBS1 gene was genotyped and provided no evidence for loss of heterozygosity in the NHL cases with mutations or in the NHL population overall. These results suggest that mutations in NBS1 do not play a major role in the development of NHL in the United States. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


p53 gene Mutations and rearrangements in
✍ Po-Min Chen; Tzeon-Jye Chiou; Ruey-Kuen Hsieh; Frank S. Fan; Chiau-Jun Chu; Chin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## Background: Alterations of the p53 gene have been associated with the progression of certain human malignancies. to establish further the correlation between p53 gene alterations and progression of non-hodgkin's lymphomas (nhls), the authors analyzed both mutations and rearrangements of the p53

Germline mutations and polymorphisms in
✍ Julie Osborne; Annette Lake; Freda E. Alexander; G. Malcolm Taylor; Ruth F. Jarr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 265 KB

## Abstract Somatic inactivation of __NFKBIA__, the gene encoding IκBα, is a frequent occurrence in the malignant Hodgkin and Reed‐Sternberg (HRS) cells of Hodgkin lymphoma (HL). Impairment of IκBα function results in deregulated NF‐κB activity, a characteristic of HRS cells. The molecular basis fo

Increased risk of gastrointestinal lymph
✍ Jan Steffen; Galina Maneva; Lidia Popławska; Raymonda Varon; Olga Mioduszewska; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB

## Abstract The __NBS1__ gene mutation, 657del5, frequent in the Slavic populations of Central Europe, is found in most patients with Nijmegen breakage syndrome (NBS), a recessive autosomal disorder with a very high incidence of non‐Hodgkin lymphoma (NHL). We have previously described 2 heterozygou

New mutations and protein variants of NB
✍ Alessandra Tessitore; Leda Biordi; Vincenzo Flati; Elena Toniato; Paolo Marchett 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

## Abstract Alterations of the __NBS1__ gene are responsible for Nijmegen breakage syndrome (NBS), which is characterized by chromosomal instability, radiosensitivity, and cancer predisposition. NBS1 protein (__Nibrin__) is part of a molecular complex (__NBS1__– __MRE11A–RAD50__) that is functional

Analysis of PTEN mutations and deletions
✍ Marion P. Butler; Steven I. Wang; R.S.K. Chaganti; Ramon Parsons; Riccardo Dalla 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in ϳ5